Cargando…

Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2

Testicular neuroendocrine tumors (NET) or carcinoid tumors are rare neoplasms which represent 1% of all testicular tumors and can be divided into 3 subgroups: pure primary testicular NET, primary testicular NET associated with a teratoma, and NET metastases to the testis. We report an unusual presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Epperson, Jonathan R., Pope, Necia M., Abuzeid, Margaret J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792543/
https://www.ncbi.nlm.nih.gov/pubmed/24171129
http://dx.doi.org/10.1155/2013/709352
_version_ 1782286860971671552
author Epperson, Jonathan R.
Pope, Necia M.
Abuzeid, Margaret J.
author_facet Epperson, Jonathan R.
Pope, Necia M.
Abuzeid, Margaret J.
author_sort Epperson, Jonathan R.
collection PubMed
description Testicular neuroendocrine tumors (NET) or carcinoid tumors are rare neoplasms which represent 1% of all testicular tumors and can be divided into 3 subgroups: pure primary testicular NET, primary testicular NET associated with a teratoma, and NET metastases to the testis. We report an unusual presentation of a primary testicular neuroendocrine tumor in a 39-year-old male who presented after a physical altercation during a soccer game. Histology showed a diffuse infiltrating tumor with extensive involvement of the tunica albuginea and tunica vaginalis. Immunohistochemical expression of CD56, synaptophysin, and chromogranin A was strongly positive in the tumor cells. Foci of tumor cell necrosis and occasional mitotic figures as well as extensive lymph-vascular invasion were also identified. A review of the literature reveals differing opinions on the prognostic significance of primary tumor size, mitotic index, tumor necrosis, and nuclear atypia. In our patient, the increased mitotic rate (3–5 mitotic figures per 10 hpf and a Ki-67 index of 5%), foci of necrosis, and mild to moderate nuclear atypia warranted a diagnosis of neuroendocrine tumor grade 2, formerly atypical carcinoid. Long term surveillance in these patients is essential as metastasis occurs in up to 15% of cases. At the 6-month followup, the patient remains symptom free.
format Online
Article
Text
id pubmed-3792543
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37925432013-10-29 Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2 Epperson, Jonathan R. Pope, Necia M. Abuzeid, Margaret J. Case Rep Pathol Case Report Testicular neuroendocrine tumors (NET) or carcinoid tumors are rare neoplasms which represent 1% of all testicular tumors and can be divided into 3 subgroups: pure primary testicular NET, primary testicular NET associated with a teratoma, and NET metastases to the testis. We report an unusual presentation of a primary testicular neuroendocrine tumor in a 39-year-old male who presented after a physical altercation during a soccer game. Histology showed a diffuse infiltrating tumor with extensive involvement of the tunica albuginea and tunica vaginalis. Immunohistochemical expression of CD56, synaptophysin, and chromogranin A was strongly positive in the tumor cells. Foci of tumor cell necrosis and occasional mitotic figures as well as extensive lymph-vascular invasion were also identified. A review of the literature reveals differing opinions on the prognostic significance of primary tumor size, mitotic index, tumor necrosis, and nuclear atypia. In our patient, the increased mitotic rate (3–5 mitotic figures per 10 hpf and a Ki-67 index of 5%), foci of necrosis, and mild to moderate nuclear atypia warranted a diagnosis of neuroendocrine tumor grade 2, formerly atypical carcinoid. Long term surveillance in these patients is essential as metastasis occurs in up to 15% of cases. At the 6-month followup, the patient remains symptom free. Hindawi Publishing Corporation 2013 2013-09-19 /pmc/articles/PMC3792543/ /pubmed/24171129 http://dx.doi.org/10.1155/2013/709352 Text en Copyright © 2013 Jonathan R. Epperson et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Epperson, Jonathan R.
Pope, Necia M.
Abuzeid, Margaret J.
Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title_full Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title_fullStr Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title_full_unstemmed Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title_short Rare Testicular Tumor Discovered by Assault: An Unusual Presentation of a Primary Testicular Neuroendocrine Tumor Grade 2
title_sort rare testicular tumor discovered by assault: an unusual presentation of a primary testicular neuroendocrine tumor grade 2
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792543/
https://www.ncbi.nlm.nih.gov/pubmed/24171129
http://dx.doi.org/10.1155/2013/709352
work_keys_str_mv AT eppersonjonathanr raretesticulartumordiscoveredbyassaultanunusualpresentationofaprimarytesticularneuroendocrinetumorgrade2
AT popeneciam raretesticulartumordiscoveredbyassaultanunusualpresentationofaprimarytesticularneuroendocrinetumorgrade2
AT abuzeidmargaretj raretesticulartumordiscoveredbyassaultanunusualpresentationofaprimarytesticularneuroendocrinetumorgrade2